ARCHIVES

FDA Approves Rituxan For CLL

This article is from The Cancer Letter archive.

Vol. 36 No. 06 | February 19, 2010

Download PDF Visit The Full Archive

Related Articles

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

February 25, 2000

In Brief: Sharp Won’t Take MIT Presidency; Brow returns To NCI; Goldman Succeeds Lawrence At MCV

March 9, 1990

DCT Board Okays Consideration Of New New Heavy Particle Therapy Studies

March 8, 1985

Editorial: A Record-Breaking Year for The Cancer Letter

December 19, 2014

NCI Management Director Leaving For Case Institute.

October 12, 2001

DCE Board Approves Two New Grant Programs, New Contract, Recompetitions Totaling $22 Mil.

March 9, 1990